Yoram Dekel

ORCID: 0000-0003-1384-0503
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Bladder and Urothelial Cancer Treatments
  • Urinary and Genital Oncology Studies
  • Urological Disorders and Treatments
  • Urinary Bladder and Prostate Research
  • Renal cell carcinoma treatment
  • Kidney Stones and Urolithiasis Treatments
  • Urinary Tract Infections Management
  • Renal and related cancers
  • Pediatric Urology and Nephrology Studies
  • Pelvic floor disorders treatments
  • Renal and Vascular Pathologies
  • Ureteral procedures and complications
  • Urologic and reproductive health conditions
  • Prostate Cancer Diagnosis and Treatment
  • Prostate Cancer Treatment and Research
  • Diverticular Disease and Complications
  • Air Quality and Health Impacts
  • Genital Health and Disease
  • Genetic factors in colorectal cancer
  • Sexual function and dysfunction studies
  • Multiple and Secondary Primary Cancers
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Pancreatic and Hepatic Oncology Research
  • Noise Effects and Management
  • Sexual Differentiation and Disorders

Carmel Medical Center
2014-2025

Technion – Israel Institute of Technology
2021-2022

Tel Aviv University
2001-2010

Rabin Medical Center
2001-2008

Heilbronn University
2005

Heidelberg University
2005

Lev Hasharon Hospital
2002

Retrograde ureteral stenting is often considered the first line option for relieving obstruction when temporary drainage indicated. Several retrospective studies have implied that in cases of extrinsic retrograde may fail and, therefore, percutaneous nephrostomy required. We examined efficacy resolving and identified clinical radiological parameters predicting failure.Enrolled our prospective study were 92 consecutive patients with obstruction, which was bilateral 8. attempted all by...

10.1016/s0022-5347(05)65666-2 article EN The Journal of Urology 2001-11-01

Background and Purpose: More than a decade after the first description of laparoscopic nephrectomy, an increasing number procedures are being performed worldwide. Nevertheless, there still exists significant lack standardized training programs to teach ablative and, most important, reconstructive operations (i.e., pyeloplasty, radical prostatectomy). We evaluated validated new step-by-step program improve skills enable trainees not experienced in laparoscopy perform urethrovesical...

10.1089/end.2005.19.230 article EN Journal of Endourology 2005-03-01

Hypogonadism is commonly linked to type 2 diabetes mellitus (T2DM), with testosterone replacement therapy (TRT) representing a key treatment option. Sodium glucose cotransporter-2 inhibitors (SGLT-2i) class part of T2DM management. Both treatments can increase Hct, Hb and RBC levels potential risk for secondary erythrocytosis. This study compares changes between patients treated without SGLT-2i TRT hypogonadism. Data from Clalit Healthcare Services (2015-2023) was analysed male Mixed linear...

10.1002/edm2.70064 article EN cc-by Endocrinology Diabetes & Metabolism 2025-06-03

Conservative treatment of upper urinary tract tumors has been popularized during the last decade. Like in bladder cancer management, localized adjuvant therapy advocated to reduce risk disease recurrence or progression. In this study we tested feasibility creating vesicoureteral reflux (VUR) using a Double-J stent (Medical Engineering Corp., New York, York) as measure efficacy for intravesical ureter and renal collecting system.The cohort included 100 consecutive patients whom was inserted...

10.1097/01.ju.0000147747.89028.64 article EN The Journal of Urology 2005-02-11

Gallbladder carcinoma is rare and fatal, conventional therapies have been disappointing. Epithelial cell adhesion molecule (EpCAM) serves as a prognostic marker in various carcinomas target of antibody-based therapies. Our purpose was to examine the expression EpCAM gallbladder relation tumor grade, disease stage, patient survival. tissue specimens from 25 patients attending our center between 1991 2004 were immunohistochemically stained for EpCAM. The intensity extent staining analyzed,...

10.1309/h8jeeaeb69j3kynd article EN American Journal of Clinical Pathology 2008-02-20

The Butterfly Prostatic Retraction device is a novel transurethral implant designed to dilate the prostatic urethra and treat lower urinary tract symptoms. We assessed its safety, efficacy impact on flow, ejaculation, quality of life.We included 64 men, treated for benign prostate hyperplasia at least 1 year. All patients had Qmax≤ 13 mL/s IPSS >12. Insertion was performed via cystoscopy. Follow-up visits were 2 weeks, 1, 3, 6, 12 months uroflowmetry, IPSS, QoL, sexual function...

10.1159/000528415 article EN cc-by-nc Urologia Internationalis 2023-01-01

Nephron-sparing surgery has emerged as the treatment of choice for small renal masses. However, its role in larger tumors remains controversial. In this study, we compare outcomes laparoscopic partial nephrectomy (LPN) vs those radical (LRN) T2 tumors.Thirteen patients who had LPN and 16 LRN were retrospectively analyzed preoperative factors (age, gender, comorbidities, hemoglobin, creatinine levels estimated glomerular filtration rate [eGFR]), operative perioperative characteristics (tumor...

10.1089/end.2018.0199 article EN Journal of Endourology 2018-07-24

Radical cystectomy (RC) is the standard treatment for muscle invasive bladder cancer (MIBC). Neoadjuvant chemotherapy (NAC) associated with improved patient survival. The impact of NAC on nutritional status understudied, while association between malnutrition and poor surgical outcomes well known. This study aims to examine NAC, impairment, post-operative morbidity.

10.3390/nu13124471 article EN Nutrients 2021-12-14

To evaluate the associations of peri-operative neutrophil-to-lymphocyte ratio (NLR) and change in NLR with survival after radical cystectomy.We retrospectively reviewed a multicentre cohort patients bladder cancer who underwent cystectomy between 2010 2020. Preoperative NLR, postoperative delta-NLR (postoperative minus preoperative NLR) divided by were calculated. Patients stratified based on elevation and/ or above median values. Multivariable Cox regression models used to survival.The...

10.1111/bju.15757 article EN cc-by-nc BJU International 2022-04-27

Objective To investigate the immunohistochemical expression of topoisomerase II‐α (TII‐α, a nuclear enzyme, which increases rapidly at end S to G2/M phase and declines when mitosis ends) in bladder urothelial neoplasms (transitional cell carcinoma), its correlation with grade, stage survival. patients methods Histological sections from 57 were stained immunohistochemically for TII‐α expression; percentage positive cells area greatest staining was recorded as index. Results all samples except...

10.1046/j.1464-410x.2003.04118.x article EN BJU International 2003-03-26

10.1016/s0090-4295(02)01962-3 article EN Urology 2002-12-01

Previous clinical studies of the combination local intravesical hyperthermia with cytostatic drugs for treatment Superficial Transitional Cell Carcinoma urinary bladder (STCCB) showed encouraging results both in reducing recurrence rate to 20-30% within 2 years and ablative success 79%. Our objectives were evaluate tissue adjacent organs during following treatment. An catheter equipped a radio-frequency antenna (Synergo SB-TS 101.1 System) was used chemotherapy (mitomycin C) instilled vivo...

10.1046/j.1365-2613.2003.00346.x article EN International Journal of Experimental Pathology 2003-06-01
Coming Soon ...